Patents by Inventor Kristin L.M. Boylan

Kristin L.M. Boylan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTI-PROTEIN CLASSIFIER FOR DETECTING EARLY-STAGE OVARIAN CANCER
    Publication number: 20230408522
    Abstract: In one aspect, the present disclosure relates to a method for determining risk of ovarian cancer in a patient, the method including: providing a biological sample from the patient; measuring a level of CA1225 in the biological sample; measuring a level of SEZ6L in the biological sample; and identifying that the patient is at risk of ovarian cancer based on the level of CA125 and the level of SEZ6L. In one or more embodiments, the method further includes measuring a level of HE4 and ITGAV. In another aspect, the present disclosure relates to a kit, system, or computer program for performing a method described herein.
    Type: Application
    Filed: June 9, 2023
    Publication date: December 21, 2023
    Inventors: Amy Patrice Skubitz, Kristin L.M. Boylan, Ashley Jenna Petersen, Timothy Kaehler Starr
  • Inhibitors of cell adhesion
    Patent number: 10907212
    Abstract: Nectin-4 and Nectin-1 in cancer progression/development and as a therapeutic target for cancer.
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: February 2, 2021
    Assignee: Regents of the University of Minnesota
    Inventors: Amy P. Skubitz, Kristin L. M. Boylan, Petra Buchanan, Rory Manion
  • INHIBITORS OF CELL ADHESION
    Publication number: 20170335404
    Abstract: Nectin-4 and Nectin-1 in cancer progression/development and as a therapeutic target for cancer.
    Type: Application
    Filed: May 15, 2017
    Publication date: November 23, 2017
    Inventors: Amy P. Skubitz, Kristin L.M. Boylan, Petra Buchanan, Rory Manion